BioInvent International AB (publ)
BOVNFOTCHealthcare● Active
$6.63
+$3.34(+101.61%)
Market Cap$436282920
P/E Ratio—
52W High$6.63
52W Low$3.2886
BioInvent International AB (publ)（BOVNF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BOVNF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.04B | $0.07B | $0.33B | $0.02B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.23B | $0.04B | $0.07B | $0.33B | $0.02B |
| Gross Margin %(computed) | 100.25% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.50B | $0.46B | $0.39B | $0.33B | $0.26B |
| G&A Expenses | $0.07B | $0.06B | $0.05B | $0.05B | $0.04B |
| Total Operating Expenses | $0.58B | $0.52B | $0.44B | $0.38B | $0.30B |
| Operating Income | ($0.35B) | ($0.47B) | ($0.37B) | ($0.05B) | ($0.28B) |
| Operating Margin %(computed) | -155.14% | — | -517.68% | -15.61% | — |
| Interest Income | $0.02B | $0.04B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.33B) | ($0.43B) | ($0.33B) | ($0.04B) | ($0.28B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.33B) | ($0.43B) | ($0.33B) | ($0.03B) | ($0.28B) |
| Net Margin %(computed) | -146.96% | -960.87% | -462.22% | -10.45% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.07 | $-6.53 | $-5.02 | $-0.55 | $-5.15 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.07B | 0.06B | 0.05B |
| EBITDA | ($0.33B) | ($0.46B) | ($0.31B) | ($0.03B) | ($0.26B) |
| EBITDA Margin %(computed) | -146.37% | — | -437.59% | -8.32% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · SEK · B
深入了解BioInvent International AB (publ)
关于BioInvent International AB (publ)（BOVNF）损益表
BioInvent International AB (publ)（BOVNF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BOVNF实现营收$0.23B，毛利润$0.23B（毛利率100.25%），净利润($0.33B)（净利率-146.96%）。
常见问题
BOVNF · 4 问BioInvent International AB (publ)（BOVNF）2025财年营收为$0.23B，同比up405.6%。
BOVNF revenueBOVNF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09